{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:16:21Z","timestamp":1787019381646,"version":"build-2736575974"},"reference-count":34,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100015769","name":"Dexcom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Diabetes Sci Technol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Up to one-third of people with gestational diabetes (GDM) will have persistent dysglycemia, and more than half do not complete the recommended postpartum oral glucose tolerance test (OGTT). This study assessed the use of blinded postpartum continuous glucose monitoring (CGM) to detect dysglycemia by assessing return rates, participant experience, and power to predict OGTT results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>Blinded CGM was placed on postpartum day 1 to 3 before discharge from the hospital and again at six weeks after pregnancy complicated by GDM and worn at home for up to 10 days. Participants mailed the CGM back and were encouraged to undergo standard of care six-week OGTT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Fifty women (36 \u00b1 6 years old; 40% non-Hispanic white, 24% non-Hispanic black, 22% Asian, 14% Hispanic; 34% Medicaid insured) were consented. First CGM was completed by 86%, second CGM was completed by 60%, and postpartum OGTT was performed by 68%. Mean first sensor glucose was 121.8 \u00b1 14.1 mg\/dL. Dysglycemia on OGTT was diagnosed in seven participants: six with impaired glucose tolerance (18%) and one with diabetes (3%). Percent time &lt;96% in the range 70 to 180 mg\/dL predicted abnormal OGTT with positive predictive value of 54% and negative predictive value of 100%. The sensitivity and specificity of CGM to predict postpartum dysglycemia were 100% and 78%, respectively. If given a choice, 94% of participants would prefer CGM over OGTT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Postpartum CGM is a reasonable and convenient initial postpartum screen for postpartum dysglycemia with high completion rates, sensitivity, and acceptability ratings. Percent time in range 70 to 180 mg\/dL had strong predictive power for OGTT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/19322968251351819","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T07:21:07Z","timestamp":1751527267000},"page":"1164-1170","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Postpartum Continuous Glucose Monitoring to Detect Dysglycemia After Gestational Diabetes"],"prefix":"10.1177","volume":"20","author":[{"given":"Camila","family":"Cabrera","sequence":"first","affiliation":[{"name":"Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selassie","family":"Ogyaadu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Levister","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslihan","family":"Ipek","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-2578","authenticated-orcid":false,"given":"Carol J.","family":"Levy","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7940-2624","authenticated-orcid":false,"given":"Grenye","family":"O\u2019Malley","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0085"},{"issue":"2","key":"e_1_3_3_3_2","article-title":"ACOG practice bulletin No. 190: gestational diabetes mellitus","volume":"131","author":"American College of Obstetricians and Gynecologists","year":"2018","unstructured":"American College of Obstetricians and Gynecologists ACOG practice bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49-e64.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/JPN.0000000000000399"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005324"},{"key":"e_1_3_3_6_2","volume-title":"Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications","author":"World Health Organization","year":"1999","unstructured":"World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Geneva: WHO; 1999."},{"key":"e_1_3_3_7_2","article-title":"Management of diabetes in pregnancy: standards of care in diabetes\u20142024","volume":"47","author":"American Diabetes Association 15","year":"2024","unstructured":"American Diabetes Association 15. Management of diabetes in pregnancy: standards of care in diabetes\u20142024. Diabet Care. 2024;47(suppl 1):S282-S94.","journal-title":"Diabet Care"},{"key":"e_1_3_3_8_2","article-title":"Undiagnosed type 2 diabetes during pregnancy is associated with increased perinatal mortality: a large population-based cohort study in Ontario, Canada","author":"Lee D","year":"2020","unstructured":"Lee D, Booth GL, Ray JG, Ling V, Feig DS. Undiagnosed type 2 diabetes during pregnancy is associated with increased perinatal mortality: a large population-based cohort study in Ontario, Canada. Diabet Med. 2020.","journal-title":"Diabet Med"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-010-0110-x"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000483809.07409.41"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000483794.93053.37"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.01.003"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2016.1271411"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1583193"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1409"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0087"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000930592.22515.7b"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2017.159"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.07.035"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2023.01.005"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.11.303"},{"issue":"1","key":"e_1_3_3_22_2","first-page":"45","article-title":"Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients","volume":"65","author":"Clemente Le\u00f3n M","year":"2018","unstructured":"Clemente Le\u00f3n M, Bilbao Gass\u00f3 L, Moreno-Gald\u00f3 A, et al. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients. Endocrinol Diabetes Nutr (Engl Ed). 2018;65(1):45-51.","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.131130"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.01.002"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)08751-8"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"e_1_3_3_29_2","unstructured":"R Core Team. RA language and environment for statistical computing. R Foundation for Statistical Computing Vienna Austria. https:\/\/www.r-project.org\/. 2020."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216851"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02763"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002423"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2008.1132"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-2111"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1226"}],"container-title":["Journal of Diabetes Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968251351819","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19322968251351819","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968251351819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:58:48Z","timestamp":1784635128000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19322968251351819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1177\/19322968251351819"],"URL":"https:\/\/doi.org\/10.1177\/19322968251351819","relation":{},"ISSN":["1932-2968","1932-2968"],"issn-type":[{"value":"1932-2968","type":"print"},{"value":"1932-2968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}